Tokyo Joe's Cafe / Anything goes Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Anything goes

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Charles J who wrote (4043)	4/2/1998 6:37:00 PM
From: Bradpalm1	Read Replies (1) of 34592

Charles J, I'm not sure what SciClone (SCLN) could possibly know which could provoke so much optimism. I've done some DD on this company and have found that their product, Zadaxin, continues to be unimpressive in Phase II and III studies. Initial results for its use in liver cancer patients is interesting but very preliminary (only 12 patients over 6 months). Further, Zadaxin has been approved in China for the treatment of Hepatitis B for the last 2 years but is still apparently used by very few physicians. If you have any further information concerning this company please let me know. Bradpalm1

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next